Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 09, 2023 16:50 ET | Source: Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences

RESEARCH TRIANGLE PARK, N.C., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the...
November 06, 2023 05:59 ET | Source: Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business Update

~ PEDMARK® Net Product Revenue of $6.5 Million, a 96% Increase Compared to Second Quarter ~ ~ Strong Commercial Uptake Underscoring Significant Unmet Medical Need ~ ~ Received Approval in October...
October 30, 2023 06:45 ET | Source: Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 6, 2023

RESEARCH TRIANGLE PARK, N.C., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the...
September 07, 2023 05:59 ET | Source: Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences

RESEARCH TRIANGLE PARK, N.C., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the...
August 03, 2023 05:59 ET | Source: Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Announces Second Quarter 2023 Financial Results and Provides Business Update

~ Growing Physician Awareness and Usage of PEDMARK® Drove Quarterly Revenue Growth of 98% ~ ~Fennec Expands Leadership Team with the Appointment of Adrian Haigh as Chief Operating Officer ~ ~...
July 31, 2023 05:30 ET | Source: Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals to Report Second Quarter 2023 Financial Results on August 3, 2023

RESEARCH TRIANGLE PARK, N.C., July 31, 2023 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the...
June 12, 2023 17:00 ET | Source: Fennec Pharmaceuticals Inc.

Fennec Announces Results of Annual Meeting

RESEARCH TRIANGLE PARK, N.C., June 12, 2023 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy...
June 06, 2023 05:44 ET | Source: Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Announces European Commission Marketing Authorization for Pedmarqsi™ (sodium thiosulfate) to Reduce the Risk of Hearing Loss in Pediatric Oncology Patients

RESEARCH TRIANGLE PARK, N.C., June 06, 2023 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced Pedmarqsi™–...
May 11, 2023 06:01 ET | Source: Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update

~ Strong PEDMARK® Commercial Momentum Building in 2023 with Broad Payor and Medicaid Coverage ~ ~ PEDMARK® Permanent J-Code Effective April 1, 2023 ~ ~ Recent Positive CHMP Opinion in EU...
May 08, 2023 06:15 ET | Source: Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals to Report First Quarter 2023 Financial Results on May 11, 2023

RESEARCH TRIANGLE PARK, N.C., May 08, 2023 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the...